Agriculture Dept Open to Engagement Over Regulatory Concerns in New Plant Improvement Act
The DoA has signalled that it is open to engaging with stakeholders who have raised concerns about the recently published hemp regulations under the Plant Improvement Act . The first of such meetings has been scheduled for the end of January 2026 between the Registrar of the Plant Improvement Act and a delegation led by Charl Botha of H3 Legal Solutions.
Medical Cannabis Marketing Now Positioning Cannabis as a Mainstream Healthcare Product Rather than Alternative Medicine
Leading international cannabis consultancy Prohibition Partners says the European medical cannabis market is maturing at speed, with providers focused on return on investment and a shift in marketing strategies. Cannabis is already well-known as an ‘alternative medicine’, but now marketing departments are looking at repositioning it as part of a cannabis ‘standardized healthcare’ package.
Ghanaian Stakeholders Appeal to Parliament to Rethink ‘Unrealistic and Exclusionary’ Hemp Licence Fees
Ghana’s leading hemp activist organization, Hempire Agric Ghana (HAG) is to take up the shock hemp licensing fee issue with Parliament. HAG’s Nana Kwaku Agyemang (pictured here) says the proposed fees, the most expensive in the world, are unrealistic and exclusionary and out of kilter with the market.
Global Perspective: New Markets, New Restrictions and the Rise of Telemedicine
Internationally, the cannabis industry is likely to see further advances in telemedicine as the main channel to market for medical cannabis in the year ahead, while Canada is likely to assert its leadership on the world stage. But watch out for new restrictrions kicking in in new markets and possible oversupply in 2026 – and keep an eye on Thailand